Dutoit, V., & Herold-Mende, C. (2018). Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma. OncoImmunology, 7(2), . https://doi.org/10.1080/2162402X.2017.1391972
Chicago-Zitierstil (17. Ausg.)Dutoit, Valérie, und Christel Herold-Mende. "Antigenic Expression and Spontaneous Immune Responses Support the Use of a Selected Peptide Set from the IMA950 Glioblastoma Vaccine for Immunotherapy of Grade II and III Glioma." OncoImmunology 7, no. 2 (2018). https://doi.org/10.1080/2162402X.2017.1391972.
MLA-Zitierstil (9. Ausg.)Dutoit, Valérie, und Christel Herold-Mende. "Antigenic Expression and Spontaneous Immune Responses Support the Use of a Selected Peptide Set from the IMA950 Glioblastoma Vaccine for Immunotherapy of Grade II and III Glioma." OncoImmunology, vol. 7, no. 2, 2018, https://doi.org/10.1080/2162402X.2017.1391972.